Cargando…

Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension

Given the difficulty of diagnosing early-stage pulmonary arterial hypertension (PAH) due to the lack of signs and symptoms, and the risk of an open lung biopsy, the precise pathological features of presymptomatic stage lung tissue remain unknown. It has been suggested that the maximum elevation of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakao, Seiichiro, Voelkel, Norbert F., Tanabe, Nobuhiro, Tatsumi, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493808/
https://www.ncbi.nlm.nih.gov/pubmed/26150101
http://dx.doi.org/10.1186/s12931-015-0246-y
_version_ 1782379985546248192
author Sakao, Seiichiro
Voelkel, Norbert F.
Tanabe, Nobuhiro
Tatsumi, Koichiro
author_facet Sakao, Seiichiro
Voelkel, Norbert F.
Tanabe, Nobuhiro
Tatsumi, Koichiro
author_sort Sakao, Seiichiro
collection PubMed
description Given the difficulty of diagnosing early-stage pulmonary arterial hypertension (PAH) due to the lack of signs and symptoms, and the risk of an open lung biopsy, the precise pathological features of presymptomatic stage lung tissue remain unknown. It has been suggested that the maximum elevation of the mean pulmonary arterial pressure (P(pa)) is achieved during the early symptomatic stage, indicating that the elevation of the mean P(pa) is primarily driven by the pulmonary vascular tone and/or some degree of pulmonary vascular remodeling completed during this stage. Recently, the examination of a rat model of severe PAH suggested that the severe PAH may be primarily determined by the presence of intimal lesions and/or the vascular tone in the early stage. Human data seem to indicate that intimal lesions are essential for the severely increased pulmonary arterial blood pressure in the late stage of the disease. However, many questions remain. For instance, how does the pulmonary hemodynamics change during the course of the disease, and what drives the development of severe PAH? Although it is generally acknowledged that both pulmonary vascular remodeling and the vascular tone are important determinants of an elevated pulmonary arterial pressure, which is the root cause of the time-dependent progression of the disease? Here we review the recent histopathological concepts of PAH with respect to the progression of the lung vascular disease.
format Online
Article
Text
id pubmed-4493808
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44938082015-07-08 Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension Sakao, Seiichiro Voelkel, Norbert F. Tanabe, Nobuhiro Tatsumi, Koichiro Respir Res Review Given the difficulty of diagnosing early-stage pulmonary arterial hypertension (PAH) due to the lack of signs and symptoms, and the risk of an open lung biopsy, the precise pathological features of presymptomatic stage lung tissue remain unknown. It has been suggested that the maximum elevation of the mean pulmonary arterial pressure (P(pa)) is achieved during the early symptomatic stage, indicating that the elevation of the mean P(pa) is primarily driven by the pulmonary vascular tone and/or some degree of pulmonary vascular remodeling completed during this stage. Recently, the examination of a rat model of severe PAH suggested that the severe PAH may be primarily determined by the presence of intimal lesions and/or the vascular tone in the early stage. Human data seem to indicate that intimal lesions are essential for the severely increased pulmonary arterial blood pressure in the late stage of the disease. However, many questions remain. For instance, how does the pulmonary hemodynamics change during the course of the disease, and what drives the development of severe PAH? Although it is generally acknowledged that both pulmonary vascular remodeling and the vascular tone are important determinants of an elevated pulmonary arterial pressure, which is the root cause of the time-dependent progression of the disease? Here we review the recent histopathological concepts of PAH with respect to the progression of the lung vascular disease. BioMed Central 2015-07-08 2015 /pmc/articles/PMC4493808/ /pubmed/26150101 http://dx.doi.org/10.1186/s12931-015-0246-y Text en © Sakao et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Sakao, Seiichiro
Voelkel, Norbert F.
Tanabe, Nobuhiro
Tatsumi, Koichiro
Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension
title Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension
title_full Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension
title_fullStr Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension
title_full_unstemmed Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension
title_short Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension
title_sort determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493808/
https://www.ncbi.nlm.nih.gov/pubmed/26150101
http://dx.doi.org/10.1186/s12931-015-0246-y
work_keys_str_mv AT sakaoseiichiro determinantsofanelevatedpulmonaryarterialpressureinpatientswithpulmonaryarterialhypertension
AT voelkelnorbertf determinantsofanelevatedpulmonaryarterialpressureinpatientswithpulmonaryarterialhypertension
AT tanabenobuhiro determinantsofanelevatedpulmonaryarterialpressureinpatientswithpulmonaryarterialhypertension
AT tatsumikoichiro determinantsofanelevatedpulmonaryarterialpressureinpatientswithpulmonaryarterialhypertension